Abstract
Purpose
The purpose of this longitudinal study was to track the symptom experience in a sample of cancer patients, determine the persistence of cancer symptoms and symptom burden, and examine the relationship between symptoms and QOL over time.
Methods
Five hundred forty-two patients provided longitudinal data, completing surveys over a 12-month period. Patients had breast, colorectal, gynecologic, lung, or prostate cancer with stage 1, 2, or 3 disease. Surveys included the Memorial Symptom Assessment Scale and the Functional Assessment of Cancer Therapy-General Scale and were administered every 3 months. Demographic and clinical information and comorbidities were collected from the tumor registry.
Results
The number and type of symptoms experienced by patients varied by cancer type, but about 90 % of patients reported one or more symptoms—with prostate cancer patients reporting fewer symptoms and colorectal patients, more symptoms. Prostate patients also had the lowest symptom burden at every time point. Overall, symptom burden decreased over time, as did the Physical subscale for the MSAS. Quality of life was stable over time, except for physical well-being, which improved. Quality of life was negatively correlated with symptom burden at every time point.
Conclusions
The differences in symptom experience by cancer type suggest that assessment and management of symptoms must be individually tailored or at least adjusted by cancer type. While symptom burden decreased over time, residual symptom burden was still noteworthy. As quality of life was persistently negatively correlated with symptom burden, the results suggest the need for comprehensive symptom assessment and management.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: Cancer J for Clin 62(1):10–29
National Cancer Institute (2011) US cancer survivors grow to nearly 12 million. http://www.cancer.gov/newscenter/pressreleases/2011/survivorshipMMWR2011. Accessed 3 Feb 2012
Portenoy RK, Thaler HT, Kornblith AB et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183–189
Baggott C, Dodd M, Kennedy N et al (2009) Multiple symptoms in pediatric oncology patients: a systematic review. J Pediatr Oncol Nurs 26:325–339
Chang VT, Hwang SS, Feuerman M et al (2000) Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88:1175–1183
Kroenke K, Zhong X, Theobald D et al (2010) Somatic symptoms in patients with cancer experiencing pain or depression. Arch Intern Med 170(18):1686–1694
Cooley ME (2000) Symptoms in adults with lung cancer: a systematic research review. J Pain Sympt Manag 19:137–153
Deshields TL, Potter P, Olsen S et al (2011) Documenting the symptom experience of cancer patients. J Support Oncol 9(6):216–223
Cella D, Davis K, Breitbart W et al (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19(14):3385–3391
Savard J, Ivers H, Villa J et al (2011) Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol 29(26):3580–3586
Andreu Y, Galdon MJ, Dura E et al (2012) A longitudinal study of psychosocial distress in breast cancer: prevalence and risk factors. Psychol Health 27(1):72–87
Burakgazi AZ, Messersmith W, Vaidya D et al (2011) Longitudinal assessment of oxaliplatin-induced neuropathy. Neurology 77(10):980–986
Harrington CB, Hansen JA, Moskowitz M et al (2010) It’s not over when it’s over: long-term symptoms in cancer survivors- a systematic review. Int J Psych Med 40(2):163–181
Cleeland CS (2006) The measurement of pain from metastatic bone disease: capturing the patient’s experience. Clin Cancer Res 12(20Pt2):6236s–6242s
Donovan HS, Hartenbach EM, Method MW (2005) Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer. Gynecol Oncol 99(2):404–411
Kim JE, Dodd MJ, Aouizerat BE et al (2009) A review of the prevalence and impact of multiple symptoms in oncology patients. J Pain Sympt Manag 37(4):715–736
Burkett VS, Cleeland CS (2007) Symptom burden in cancer survivorship. J Cancer Surviv 1(2):167–175
Kirkova J, Davis MP, Walsh D et al (2006) Cancer symptom assessment instruments: a systematic review. J Clin Oncol 24(9):1459–1473
Committee on Cancer Survivorship: Improving Care and Quality of Life, Institute of Medicine and National Research Council (2005) From cancer patient to cancer survivor: lost in transition. The National Academies, Washington
Portenoy RK, Thaler HT, Kornblith AB et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A:1326–1336
Molassiotis A, Wengstrom Y, Kearney N (2010) Symptom cluster patterns during the first year after diagnosis with cancer. J Pain Sympt Manag 39:847–858
Akin S, Can G, Aydiner A et al (2010) Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy. Eur J Oncol Nurs 14:400–409
Sun CC, Bodurka DC, Weaver CB et al (2005) Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 13:219–227
Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 11:570–579
Piccirillo J, Creech C, Zequeira R et al (1999) Inclusion of comorbidity into oncology data registries. J Registry Manag 26(2):66–70
Kaplan MH, Feinstein AR (1974) The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 27:387–404
Prigozin A, Uziely B, Musgrave CF (2010) The relationship between symptom severity and symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with early-stage breast cancer. Oncol Nurs Forum 37(6):E411–E418
Oksholm T, Miaskowski C, Kongerud JS et al (2013) Does age influence the symptom experience of lung cancer patients prior to surgery? Lung Cancer 82:156–161
Mao JJ, Armstrong K, Bowman MA et al (2007) Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med 20(5):434–443
Cheung WY, Le LW, Gagliese L, Zimmermann C (2011) Age and gender differences in symptom intensity and symptom clusters among patients with metastatic disease. Support Care Cancer 19:417–423
Kirkova J, Rybicki L, Walsh D, Aktas A (2012) Symptom prevalence in advanced cancer: age, gender, and performance status interactions. Am J Hosp Palliat Med 29(2):139–145
Mock V, Dow KH, Meares CJ et al (1997) Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24(6):991–1000
Cramp F, Daniel J (2008) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. doi:10.1002/14651858
Savard J, Villa J, Simard S et al (2011) Feasibility of a self-help treatment for insomnia comorbid with cancer. Psychooncology 20(9):1013–1019
Council NR (2008) Cancer care for the whole patient: meeting psychosocial health needs. The National Academies, Washington
Acknowledgments
This research project was funded by Barnes-Jewish Hospital which employs Dr. Deshields, Dr. Potter, and Ms. Olsen. The authors acknowledge the support of the Biostatistics Core of the Siteman Cancer Center, which is funded by the NCI Cancer Center Support Grant P30 CA091842. The authors have full control of all primary data and agree to allow the journal to review the data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deshields, T.L., Potter, P., Olsen, S. et al. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 22, 1089–1096 (2014). https://doi.org/10.1007/s00520-013-2049-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-013-2049-3